This year’s Nobel Prize in Physiology or Medicine goes to Victor Ambros and Gary Ruvkun. The Karolinska Institute announced this on Monday in Stockholm. The two scientists were honored for their discovery of microRNA and its role in post-transcriptional gene regulation. The prize is endowed with eleven million Swedish kronor, equivalent to approximately 970,000 euros. […] Nobel Prize in Medicine for Gene Researchers
The Federal Ministry of Health has contradicted the assertion that long-term care insurance is facing immediate insolvency. “Long-term care insurance is not bankrupt,” said a ministry spokeswoman on Monday in Berlin. Provisions will be made accordingly. Federal Minister of Health Karl Lauterbach (SPD) is therefore expected to present a “financial concept” shortly to support long-term care insurance. This will be effective “both in the short term and […] Ministry of Health: “Long-term care insurance is not bankrupt”
MicuRx Pharmaceuticals announced the publication of groundbreaking research on MRX-5, a novel oral oxaborole prodrug, demonstrating significant potential in the treatment of pulmonary infections caused by Mycobacterium abscessus (Mab), a severe nontuberculous mycobacterium (NTM) infection. The research was led by Dr. Gyanu Lamichhane, Associate Professor at Johns Hopkins University School of Medicine. Mab infections are notoriously difficult to treat, often requiring prolonged, complex, and poorly tolerated courses of multiple antibiotics. With no FDA-approved treatment for Mab, the results of this study are a promising step towards addressing the growing unmet clinical need for effective and convenient treatment options. Importantly, MRX-5 offers an oral alternative to current treatment regimens that are primarily intravenous and highly toxic, with failure rates exceeding 50%. MRX-5 could vastly improve patient compliance and quality of life compared to the current standard intravenous therapies
A new systematic review led by the Harvard Pilgrim Health Care Institute examined a broad body of evidence documenting the impact on children's mental health following the FDA's black box warnings linking antidepressants to suicidal thoughts and behaviors in adolescents. The data show that these warnings, intended to bring about increased monitoring of suicidal thoughts and behaviors, led to a decrease in the use of important medications and less psychiatric treatment for depression in children, as well as an increase in suicide attempts and deaths. The findings support a re-evaluation of the black box warning. Since 2003, the FDA has warned that antidepressants may be linked to suicidal thoughts and behaviors in young people. These warnings, upgraded to a black box warning (the most severe warning level) in 2005 for those under 18 and extended in 2007 to young adults up to age 24 ...
Imagine a world where your own immune cells become superheroes in the fight against cancer. This is precisely the promise of CAR T-cell therapy, a groundbreaking treatment that is already saving lives. In this therapy, a patient's own immune cells are collected, genetically modified to specifically target cancer cells, and then returned to the body. The result is a powerful new option for combating blood cancers. However, as with any superhero journey, the process of harnessing this incredible power comes with its own set of challenges. One such hurdle is that current methods for activating T-cells do not sufficiently mimic the natural environment where they interact with another crucial population of immune cells – a connection vital for T-cell activation and enhancing their cancer-fighting capabilities. In a recent study in Nature…
A blood test performed at the time of diagnosis of metastatic prostate cancer can predict which patients are likely to respond to treatment and survive the longest. It can help doctors decide which patients should receive standard treatment and which might benefit from riskier, more aggressive trials of new drugs. The research findings, part of a Phase 3 clinical trial partially funded by the National Cancer Institute (NCI) of the National Institutes of Health, were just published in JAMA Network Open. The research used CellSearch (Menarini, Inc.), an FDA-approved liquid biopsy technology from the Norris Comprehensive Cancer Center, to detect and measure CTCs in blood samples. Patients with more CTCs had a shorter median survival and a higher risk of death during the study period. Patients with more CTCs also had shorter “progression-free survival,” meaning the time period during which…
labnews.ai/ differs from other online magazines in the life sciences in several important aspects: Independence and Integrity Financial Independence: labnews.ai/ receives no donations, grants, or advertising revenue[1]. This is a significant difference from many other online magazines, which often rely on advertising revenue or sponsors. This financial independence allows labnews.ai/ to report without external influences. Editorial Freedom: As an independent online magazine, labnews.ai/ is not tied to specific companies or institutions[1]. This allows for objective reporting and critical analysis that is free from commercial interests. Quality Assurance Strict Criteria: Particularly strict criteria apply to sensitive topics such as Covid-19 reporting. Articles must have appeared in peer-reviewed journals, authors must not have any conflicts of interest, and the content must be publicly accessible[1]. This practice distinguishes labnews.ai/ from many other online magazines that may have less stringent quality controls. Expert Authors: Collaboration with specialist authors and experts ensures that the published articles…
Anyone currently seeking psychotherapy in Germany waits an average of 20 weeks for the first appointment. Demand significantly exceeds supply, even though the number of therapists working in relevant practices more than doubled between 2006 and 2021*. Psychologists at the University of Duisburg-Essen see a possible reason for this in a "diagnostic culture" and excessive sensitization within society, in which personality differences and temporary emotional crises are increasingly pathologized. As a result, people in urgent need of treatment sometimes receive no help or only delayed help. The authors propose an alternative approach. Prof. Dr. Marcus Roth from Differential Psychology and Prof. Dr. Gisela Steins from General Psychology and Social Psychology at the University of Duisburg-Essen (UDE) are well aware of the controversial nature of their statements. "But if we don't discuss the topic now, it will be a very difficult discussion when the health insurance funds due to demographic...
Capsida Biotherapeutics (“Capsida”) presented new IND-enabling data on its intravenously (IV) delivered gene therapy for Parkinson’s disease associated with GBA mutations (PD-GBA), CAP-003, that demonstrate its substantial therapeutic potential. Capsida’s next-generation therapy, using a proprietary engineered capsid, demonstrates best-in-class potential to effectively and safely treat PD-GBA. CAP-003 achieves unprecedented levels of GCase protein and activity while simultaneously detargeting the liver and dorsal root ganglion (DRGs). These data were presented in a late-breaking poster presentation at the Society for Neuroscience „Neuroscience 2024“ annual meeting being held October 5-9, 2024 in Chicago, IL.
In recent years, there have been increased reports of sudden deaths among young people, leading to the question of whether significantly more young people are unexpectedly dying in 2024. However, a detailed analysis of available data and medical findings shows that there is no evidence of a significant increase in such cases. Sudden cardiac death, defined as unexpected death within a very short period in previously healthy-appearing individuals, is a tragic reality, but it still predominantly affects older people[1]. In young people under 40, an estimated 1,000 to 2,000 cases occur per year in Germany, with some underreporting[3]. These numbers have not changed significantly in recent years. The increased public attention to this issue is more likely attributable to heightened media coverage than to an actual increase in cases. Thomas…
